X4 Pharmaceuticals, Inc. (XFOR)

4.05 +0.01 (+0.25%) USD  |  NASDAQ  |  Sep 04, 16:00
4.05 0.00 (0.00%) After-Hours: 18:22
More

X4 Pharmaceuticals Cash and Short Term Investments (Annual) : 253.80M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for XFOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 253.80M
December 31, 2024 102.06M
December 31, 2023 114.47M
December 31, 2022 122.00M
December 31, 2021 81.79M
December 31, 2020 78.97M
Date Value
December 31, 2019 126.18M
December 31, 2018 8.134M
December 31, 2017 76.79M
December 31, 2016 3.035M
December 31, 2015 6.759M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. 939.65M
Arrowhead Pharmaceuticals, Inc. 919.37M
Oncolytics Biotech, Inc. 5.202M
Sangamo Therapeutics, Inc. 20.95M
Anixa Biosciences, Inc. 15.17M